Latest Pharma-News

Single, subanesthetic-dose of ketamine infusion relatively free of side effects for patients with treatment-resistant depression

New Novartis medicine Adakveo® (crizanlizumab) approved by FDA for the treatment of individuals living with sickle cell disease

BMS and Pfizer to start a new randamized controlled trial accessing the impact of atrial fibrillation screening on health outcomes in older individuals

FDA approves Talicia To Treat bacterial infection Linked To Stomach Cancer

Zydus Cadila gets tentative approval from USFDA for Apremilast tablets for the treatment of psoriatic arthritis

New antibacterial drug approved by FDA to treat complicated urinary tract infections for antimicrobial resistance